ArticlePacing and clinical electrophysiology : PACE2026
Incidence and Determinants of Implantable Cardioverter-Defibrillator Therapy With Loss of and Impaired Consciousness.
Article in Pacing and clinical electrophysiology : PACE, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionImplantable cardioverter-defibrillators (ICDs) are important in the prevention of sudden cardiac death. However, some appropriate ICD therapies may be considered unnecessary, delivered when patients do not experience symptoms of hemodynamic instability such as loss of consciousness. Therefore, we aimed to determine the incidence of appropriate ICD therapy with loss of consciousness and impaired consciousness, as well as the psychological impact following any ICD therapy, in patients with an ICD by investigating patient-reported symptoms.
methodsIn this prospective, single-center study conducted at the University Medical Center Groningen (UMCG), 100 consecutive patients with an ICD for primary or secondary prevention indications who received ICD shock and/or ATP within the previous 6 months completed a questionnaire. The primary outcome was appropriate ICD therapy with loss of consciousness.
resultsThe patient population consisted of 100 patients, 92 (92.0%) of whom had appropriate therapy. The mean age was 62.7 ± 12.8 years and 21 (21.0%) were female. Loss of consciousness occurred in 40% of patients with appropriate ICD therapy and in 65% of patients with appropriate shocks. Determinants of appropriate ICD therapy with loss of consciousness included the shortest cycle length, ventricular fibrillation, the occurrence of shock, a secondary prevention indication for ICD, the presence of a CRT-D and the fragmentation and width of the QRS complex. The psychological impact of ICD shocks was considerable, with patients without loss of consciousness during ICD shocks suffering significantly more from anxiety than those with loss of consciousness (9 (60.0%) versus 12 (42.9%), p = 0.041).
conclusionsA considerable number of patients do not experience appropriate ICD therapy with loss of consciousness and thus experience potentially unnecessary therapy while still being at risk of sustaining the consequent psychological impact associated with ICD shocks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.